Novo Nordisk A/S (NVO)

USD 105.96

(-1.9%)

Long Term Debt Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual long term debt in 2023 was 20.52 Billion DKK , down -15.59% from previous year.
  • Novo Nordisk A/S's latest quarterly long term debt in 2024 Q1 was 16.76 Billion DKK , up 4.93% from previous quarter.
  • Novo Nordisk A/S reported annual long term debt of 24.31 Billion DKK in 2022, up 87.62% from previous year.
  • Novo Nordisk A/S reported annual long term debt of 12.96 Billion DKK in 2021, up 347.39% from previous year.
  • Novo Nordisk A/S reported quarterly long term debt of 51.6 Billion DKK for 2024 Q2, up 207.85% from previous quarter.
  • Novo Nordisk A/S reported quarterly long term debt of 24.26 Billion DKK for 2023 Q1, down -0.21% from previous quarter.

Annual Long Term Debt Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Long Term Debt of Novo Nordisk A/S (2023 - 1989)

Year Long Term Debt Long Term Debt Growth
2023 20.52 Billion DKK -15.59%
2022 24.31 Billion DKK 87.62%
2021 12.96 Billion DKK 347.39%
2020 2.89 Billion DKK -3.72%
2019 3 Billion DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK 0.0%
2015 - DKK 0.0%
2014 - DKK 0.0%
2013 - DKK 0.0%
2012 - DKK -100.0%
2011 502 Million DKK -0.4%
2010 504 Million DKK -48.04%
2009 970 Million DKK -1.45%
2008 984.25 Million DKK 2.37%
2007 961.43 Million DKK -18.2%
2006 1.17 Billion DKK -5.84%
2005 1.24 Billion DKK 4.33%
2004 1.19 Billion DKK 58.07%
2003 756.82 Million DKK -7.82%
2002 821.01 Million DKK -4.58%
2001 860.46 Million DKK -9.09%
2000 946.5 Million DKK -74.65%
1999 3.73 Billion DKK 103.47%
1998 1.83 Billion DKK 4.07%
1997 1.76 Billion DKK 86.39%
1996 945.94 Million DKK -28.4%
1995 1.32 Billion DKK -57.48%
1994 3.1 Billion DKK -7.07%
1993 3.34 Billion DKK 29.27%
1992 2.58 Billion DKK 50.94%
1991 1.71 Billion DKK 50.23%
1990 1.14 Billion DKK -27.06%
1989 1.56 Billion DKK 85.89%

Peer Long Term Debt Comparison of Novo Nordisk A/S

Name Long Term Debt Long Term Debt Difference
ADC Therapeutics SA 112.73 Million USD -18109.882%
Alto Neuroscience, Inc. 151.33 Million USD -13464.339%
Annovis Bio, Inc. - USD -Infinity%
Biohaven Pharmaceutical Holding Company Ltd. 27.56 Million USD -74360.445%
Ginkgo Bioworks Holdings, Inc. 221.83 Million USD -9153.725%
Nuvation Bio Inc. 2.03 Million USD -1008646.929%
Nuvation Bio Inc. 2.03 Million USD -1008646.929%
Arcus Biosciences, Inc. 110 Million USD -18561.818%
Theriva Biologics, Inc. 162 Thousand USD -12671504.938%
Zymeworks Inc. 22.46 Million USD -91293.972%